Eplerenone
Eplerenone is a steroidal antimineralocorticoid of the spirolactone group that is used as an adjunct in the management of chronic heart failure. Classified as a selective aldosterone receptor antagonist (SARA), it is similar to the diuretic spironolactone, though it is much more selective for the mineralocorticoid receptor in comparison (i.e., does not possess any antiandrogen, glucocorticoid, or progesterone receptor activity), and is specifically marketed for reducing cardiovascular risk in patients following a myocardial infarction. Eplerenone is a potassium-sparing diuretic, meaning that it helps the body get rid of water but not potassium. It is available under the brand name Inspra.
Pharmacology[edit | edit source]
Eplerenone selectively binds to the mineralocorticoid receptor and blocks the binding of aldosterone, a hormone that regulates the balance of water and electrolytes in the body. Aldosterone binding to mineralocorticoid receptors can cause high blood pressure and heart failure. By blocking the effect of aldosterone, eplerenone reduces the amount of sodium and water the body retains and helps to lower blood pressure.
Clinical use[edit | edit source]
Eplerenone is used for the treatment of congestive heart failure following a heart attack and also to treat high blood pressure. It is usually prescribed along with other medications. Eplerenone has been shown to reduce the risk of cardiovascular death in elderly patients after a heart attack.
Side effects[edit | edit source]
Common side effects of eplerenone include headache, dizziness, stomach pain, and fatigue. Serious side effects may include high potassium levels, irregular heartbeat, and severe allergic reactions.
See also[edit | edit source]
Drug groups | Encyclopedia | Dictionary | Cancer drugs | OTC | Alternative meds | Drugs | Medications A-Z | FDA approved products | Portal:Pharmacology
 | This pharmacology-related article is a stub. You can help WikiMD by expanding it. |
 | This cardiovascular system article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
